Compounds of Formula I and II: I II having the chemical names cis-6-fluoro-8-(3-fluoropiperidin-4-yloxy)-2-(7-(2-methoxyethoxy)imidazo[1,2-a]pyridin-3-yl)quinoline and 6-fluoro-8-(trans-3-fluoropiperidin-4-yloxy)-2-(7-(2-methoxyethoxy)imidazo[1,2-a]pyridin-3-yl)quinoline, respectively, and enantiomers and pharmaceutically acceptable salts thereof, are receptor tyrosine inhibitors useful in the treatment of diseases mediated by class 3 and class 5 receptor tyrosine kinases. The compounds of this invention have also been found to be inhibitors of Pim-1.
公式I和II的化合物:I II,其
化学名称分别为顺式-6-
氟-8-(
3-氟哌啶-4-氧基)-2-(7-(2-甲氧基乙氧基)
咪唑[1,2-a]
吡啶-3-基)
喹啉和6-
氟-8-(反-
3-氟哌啶-4-氧基)-2-(7-(2-甲氧基乙氧基)
咪唑[1,2-a]
吡啶-3-基)
喹啉,其对映异构体和药学上可接受的盐,是受体
酪氨酸激酶
抑制剂,可用于治疗由第3类和第5类受体
酪氨酸激酶介导的疾病。本发明的化合物还被发现是Pim-1的
抑制剂。